This study clearly depicts that Raffort and colleagues 1 have attempted to review existing and potential applications of artificial intelligence (AI) in the management of patients with abdominal aortic aneurysm (AAA). AI applied to health care has thrust itself impatiently into the limelight during the last decade. It promises the potential to deliver transformative change that will benefit patients, providers, and the related economies. Unsurprisingly, it is the last that has added the most fuel to the fire. Accenture, the global professional services behemoth, predicted that the health AI market will grow from U.S. $600 million to $6.6 billion between 2014 and 2021, with robot-assisted surgery being the most lucrative application of AI by some way. 2 For the patient, precision medicine offers the ability to predict which therapies will deliver the greatest benefit based on individualized variables and treatment context.
Reference link- https://www.jvascsurg.org/article/S0741-5214(19)32912-X/fulltext
